In this episode we are joined by Eric Fontana, VP of Client Solutions at Optum Life Sciences; Bethany Kalich, U.S. Medical Director, Cardiovascular at Amgen; and Christen Buseman, Director, IDN Strategy and Marketing at Amgen. Tune in to learn best practices on how RWD can be used to address questions across the clinical/drug-development life cycle and much more. This episode is sponsored by Amgen.
Summary
Using Real World Data and Evidence to Improve Healthcare
Introduction
Amgen sponsored an episode of a podcast featuring Eric Fontana, VP of Client Solutions at Optum Life Sciences; Bethany Kalich, U.S. Medical Director, Cardiovascular at Amgen; and Christen Buseman, Director, IDN Strategy and Marketing at Amgen. The episode focused on how real world data (RWD) and evidence can be used to address questions throughout the clinical/drug-development life cycle.
What is Real World Data and Evidence?
Real world data is information about patient health status or the delivery of healthcare that is routinely collected from various sources such as electronic health records, claims, billing registries, or patient-generated data. Real-world evidence is clinical evidence regarding the medical product's use and the benefits or risks from the analysis of that real world data.
Why Use Real World Data?
Amgen advocates for a move from a reactive care model to a predict and prevent mindset through leveraging real world data. This approach helps to identify at-risk patients and reduce health risks. Amgen has used real world data in several ways, including sponsoring the American College of Cardiology's Transform ACS project, collaborating with industry and health system partners to create and implement a performance platform for clinicians, and partnering with UT Southwestern in Duke Clinical Research Institute to establish a prospective registry. Finally, Amgen has also linked up claims data with available laboratory data to try to identify gaps in care for cardiovascular ASCVD populations.
Insights from the Life Science Space
Eric Fontana shared insights from the life science space, in terms of using real world data to generate evidence. He said it takes leadership, data talent, and an organizational appetite to drive change to leverage real world data. Providers are looking for better visibility into Care Pathways, granular social determinants data, and ways to account for patient leakage into outside of the health system. Real world data provides a great substrate for turning data into actionable insights that can improve population health management and hopefully patient outcomes down the road.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 12/19/2022 and can be listened here.
Subscribe to Beckers Healthcare Podcast here.